Reuters Health News Summary

Reuters Health News Summary

Following is a summary of current health news briefs. Japan scientists win backing for work on potential Nipah vaccine

A global coalition set up to fight emerging epidemics has struck a $31 million deal with scientists at Japan's University of Tokyo to speed up work on a vaccine against a brain-damaging disease caused by the Nipah virus. The Coalition for Epidemic Preparedness Innovations (CEPI) said the Tokyo University team would receive up to $31 million to advance the development and manufacturing of a shot for the bat-borne disease. China reports two new African swine fever outbreaks

China on Sunday confirmed two new outbreaks of African swine fever, one in the northern province of Hebei and the other in the northern region of Inner Mongolia, as the highly contagious disease spreads through the world's largest hog herd. The Ministry of Agriculture and Rural Affairs said the first outbreak is on a farm in the Xushui district of Baoding city which has 5,600 hogs, some of which died because of the swine fever, though it did not give a death toll. African swine fever spreads to third Vietnamese province: state media

African swine fever has been detected in a farm in Haiphong in northern Vietnam, the third province in the Southeast Asian country to be hit by the virus, state media reported on Monday. Pigs had been found dead at the farm and two of the five samples taken had tested positive to the highly contagious disease, according to a report in the Nong Nghiep Vietnam newspaper, run by the Ministry of Agriculture. United States charges man accused in leak of Singapore HIV data

Authorities in the United States have charged a man accused of leaking information on thousands of HIV victims in Singapore with possession and unlawful transfer of stolen documents. Mikhy Farrera-Brochez was deported last year from the wealthy Asian city state after serving a prison sentence for numerous drug-related and fraud offences, including lying about his own HIV status. Bayer faces second trial over alleged Roundup cancer risk

Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company's share price was rocked by a $289 million verdict in California state court. A lawsuit by California resident Edwin Hardeman against the company was scheduled to begin on Monday in federal rather than state court. The trial is also a test case for a larger litigation. More than 760 of the 9,300 Roundup cases nationwide are consolidated in the federal court in San Francisco that is hearing Hardeman's case.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.